Kexing Biopharm , Ltd. Inventory

Kexing Biopharm , Ltd. (688136.SS) currently reports a inventory of $180M as of September 2026. That compares with $120M in the prior-year period — up 41.5% year over year. Use the charts on this page to explore Kexing Biopharm , Ltd.'s inventory history and peer comparisons.

Kexing Biopharm , Ltd.'s inventory increased from $120M to $180M — a 41.5% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kexing Biopharm , Ltd. reported $180M in inventory as of September 2026. That compares with $120M in the prior-year period — up 41.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $180M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kexing Biopharm , Ltd., and consider following 688136.SS for alerts when major investors trade the stock.

Kexing Biopharm , Ltd. is classified in the Healthcare sector. On inventory, it currently shows $180M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 688136.SS with unrelated industries.